INFLIXIMAB RESTORES THE BARRIER TO E. COLI IN ACTIVE CROHN’S COLITIS VIA EFFECTS ON LIPID RAFTS

(2) Gastrointestinal Research Group, University of Calgary, Calgary, Alberta, Canada,University of Calgary,Calgary,Canada

(3) Department of Gastroenterology, Royal Liverpool University Hospital, Liverpool, UK,Royal Liverpool University Hospital,Liverpool,United Kingdom

(4) Department of Clinical and Experimental Medicine, Division of Surgery ,Linköping university,Linköping ,Sweden

(5) Department of Clinical and Experimental Medicine, Division of Surgery,Linköping university ,Linköping ,Sweden

(6) Department of Gastroenterology and Hepatology, Linköping University, Linköping Sweden,Linköping university,Linköping ,Sweden

(7) Department of Medicine, Karolinska institutet, Stockholm, and GastroCentrum, Karolinska university hospital, Stockholm.,Karolinska university ,Stockholm,Sweden

(8) Department of Clinical and Experimental Medicine, Division of Surgery,Linköping university ,Linköping,Sweden

(9) Department of Clinical and Experimental Medicine, Division of Surgery ,Linköping university ,Linköping ,Sweden

(10) Department of Clinical and Experimental Medicine, Division of Surgery ,Linköping University,Linköping,Sweden



This item was part of UEG Week 2015

This item can be cited as: United European Gastroenterology Journal; 2015: 2 (Supplement 1)

You may be interested in:

Duodenal low-grade inflammation and impaired mucosal integrity in functional dyspepsia patients
English, Abstract, European Society of Neurogastroenterology and Motility (ESNM), American Neurogastroenterology and Motility Society (ANMS), 2012

Categorisation:

  • Format
    • Abstract
  • Year
    • 2015